Risk Management for Gastrointestinal Endoscopy in Elderly Patients: Questionnaire for Patients Undergoing Gastrointestinal Endoscopy

被引：0

作者：

Umegaki, Eiji ^{[1
,2
]}

Abe, Shinya ^{[2
]}

Tokioka, Satoshi ^{[1
]}

Takeuchi, Nozomi ^{[1
]}

Takeuchi, Toshihisa ^{[1
]}

Yoda, Yukiko ^{[1
]}

Murano, Mitsuyuki ^{[1
]}

Higuchi, Kazuhide ^{[1
]}

机构：

[1] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan

[2] Osaka Med Coll Hosp Endoscopy Ctr, Takatsuki, Osaka 5698686, Japan

来源：

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION | 2010年 / 46卷 / 01期

关键词：

risk management; gastrointestinal endoscopy; questionnaire; hANP; hBNP; GLUCAGON;

D O I：

暂无

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

More elderly patients now undergo gastrointestinal endoscopy following recent advances in endoscopic techniques. In this study, we conducted a high-risk survey of endoscopies in Japan, using a questionnaire administered prior to upper gastrointestinal tract endoscopy (UGITE), and identified anticholinergic agents and glucagon preparations as high-risk premedication. We also evaluated the cardiovascular effects of anticholinergic agents and glucagon through measurements of plasma levels of human atrial natriuretic peptide (hANP) and human brain natriuretic peptide (hBNP). The subjects were 1480 patients who underwent UGITE. Nurses administered a pre-endoscopy questionnaire, questioning subjects regarding heart disease, hypertension, glaucoma, and urinary difficulties as risk factors for anticholinergic agents, and Diabetes mellitus as a risk factor for glucagon preparations. Evaluation of subjects divided into under 65 and over 65 age groups revealed that in subjects aged 65 and over, risk factors for anticholinergic agents were significantly more high than those for glucagon. Analysis of the cardiovascular effects of anticholinergic agents and glucagon, in the elderly patients showed that hANP levels were significantly higher following administration of anticholinergic agents, but the change was not significant for glucagon premedication. Taking a detailed history before UGITE with the aid of a questionnaire at the same time as informed consent is obtained, is extremely useful in terms of risk management and selection of the appropriate premedication.

引用

页码：73 / 80

页数：8

共 22 条

[1]

Amornyotin Somchai, 2007, Journal of the Medical Association of Thailand, V90, P301

[2]

[Anonymous], 2005, GASTROENTEROL ENDOS

[3]

BOUGH EW, 1978, AM J GASTROENTEROL, V69, P655

[4]

BROWN JH, 1990, PHARMACOL BASIS THER, P1560

[5] Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].

Cowie, MR ;

Struthers, AD ;

Wood, DA ;

Coats, AJS ;

Thompson, SG ;

PooleWilson, PA ;

Sutton, GC .

LANCET, 1997, 350 (9088) :1349-1353

[6]

DOTEVALL G, 1963, GASTROENTEROLOGY, V45, P364

[7]

Faigel DO, 2003, GASTROINTEST ENDOSC, V57, P446

[8] Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases [J].

Hui, AJ ;

Wong, RMY ;

Ching, JYL ;

Hung, LCT ;

Chung, SCS ;

Sung, JJY .

GASTROINTESTINAL ENDOSCOPY, 2004, 59 (01) :44-48

[9]

Kaneko E, 2004, GASTROENTEROL ENDOSC, V46, P54

[10] Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure [J].

Maisel, AS ;

Krishnaswamy, P ;

Nowak, RM ;

McCord, J ;

Hollander, JE ;

Duc, P ;

Omland, T ;

Storrow, AB ;

Abraham, WT ;

Wu, AHB ;

Clopton, P ;

Steg, PG ;

Westheim, A ;

Knudsen, CW ;

Perez, A ;

Kazanegra, R ;

Herrmann, HC ;

McCullough, PA .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (03) :161-167

← 1 2 3 →